BioPortUSA is excited to announce the expansion of its International Alliance Partner Network with the addition of UK Health Gateway. The company is lead by Jon Wilks and Roy Lilley, and provides an expert team who are familiar with regulatory affairs, quality system management, primary and secondary care development, reimbursement and distribution for the UK marketplace. They are well versed with the NHS (National Health Service) which is critical for successful market entry into the British Healthcare System. “We are thrilled to have a relationship with UK Healthway as are partner for medical device companies in the UK who may wish to enter the USA and vice versa” says Mark Lesselroth, CEO of BioPortUSA. With upcoming changes surrounding MDR and Brexit, it will be important to have a partner who has a good understanding of the landscape.

Jon Wilks agrees that having a partner in the USA will be conducive to help British medtech companies who are uncertain about what the future with Brexit will hold. “The current situation in the UK is hard to determine based on the difficulty our government is having with Brexit. It is therefore optimal to have a partnership with BioPortUSA as the American market will no doubt provide a good alternative.” Both companies will be supporting each other in the coming months with educational forums to help prep medtech companies with international expansion.

You can learn more about UK Health Gateway on their website.

Related Post

BioPortUSA opens European Office in Stuttgart Germany

BioPortUSA to Present in the UK

BioPortUSA CEO to visit Germany and England